Article

Making Pharma’s Post-Covid-19 Future Faster and Smarter

COVID-19 has sparked the reimagining of the pharmaceutical industry, illustrating the possibilities — and benefits — of fully remote commerce.

By David Weiss

The COVID-19 pandemic sparked the reimagining of the pharmaceutical industry, illustrating the possibilities — and benefits — of fully remote commerce. Among other things, we’ve learned that bringing drugs to market needn’t be a 10-year slog and that pharma can be smarter, faster, and more efficient.

David Weiss outline three lessons for the pharmaceutical industry to carry forward post-COVID:

Infuse agility and responsiveness into the sales force
Take advantage of opportunities to expedite the path to market
Simplify the supply chain with proactive strategies to address its complexities

This byline originally appeared in STAT.

Let Us Help Guide You

Complexity demands a trusted guide with the unique expertise and cross-sector versatility to deliver unwavering success. We work with organizations across regulated commercial and public sectors to catalyze transformation and pioneer new directions for the future.

Making Pharma’s Post-Covid-19 Future Faster and Smarter

COVID-19 has sparked the reimagining of the pharmaceutical industry, illustrating the possibilities — and benefits — of fully remote commerce.

Let Us Help Guide You

Stay ahead of the curve with news, insights and updates from Guidehouse about issues relevant to your organization and its work.